Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
None USD 0.00(0%)
Last update at 2025-04-07T13:00:25.037161Z
Market Cap
0.03M

Momentum Score

…

Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
2.33M
Revenue Per Share
0.03
Gross Profit TTM
0.18M
Debt / Equity
-0.50
ROE
-
Net Debt
2.82M
ROCE
11.46%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-07-31 2020-07-31 2019-07-31 2018-07-31 2017-07-31
Type yearly yearly yearly yearly yearly
Date 2021-07-31 2020-07-31 2019-07-31 2018-07-31 2017-07-31
Income before tax -2.39M -2.25M -1.81M -13.21M -65.92M
Minority interest - - - - -0.02M
Net income -2.98M -2.90M -1.81M -13.19M -65.92M
Selling general administrative 0.56M 1.54M 0.87M 0.45M 51.76M
Gross profit -0.02M -0.03M 0.18M 0.03M -10.78M
Reconciled depreciation - 0.00M 0.01M 0.02M -
Ebit -0.65M -1.70M -0.64M -1.27M -0.42M
Ebitda -0.47M -1.45M -0.62M -0.42M -62.53M
Depreciation and amortization 0.17M 0.25M 0.02M 0.85M -
Operating income -0.65M -1.70M -0.69M -0.42M -62.53M
Other operating expenses 0.56M 1.54M 2.91M 1.24M 62.54M
Interest expense 0.76M 0.46M 0.07M 0.04M 4.24M
Interest income 0.09M 0.09M 0.09M 0.05M -
Net interest income -0.67M -0.38M -0.16M -0.03M -0.04M
Income tax expense 0.59M 0.65M -0.02M -0.85M -
Total revenue 0.00M 2.33M 2.22M 0.83M 0.01M
Total operating expenses 0.56M 1.54M 0.87M 0.45M 51.76M
Cost of revenue 0.02M 0.03M 2.04M 0.79M 10.78M
Total other income expense net -1.74M -0.56M -1.10M -12.76M 0.85M
Discontinued operations - -0.43M -0.47M -0.47M -0.47M
Net income from continuing ops -2.39M -2.25M -3.68M -1.81M -13.21M
Net income applicable to common shares -17.35M -2.68M -8.44M -1.81M -13.19M
Breakdown 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Type yearly yearly yearly yearly yearly
Date 2022-07-31 2021-07-31 2020-07-31 2019-07-31 2018-07-31
Total assets 0.05M 0.05M 0.06M 1.88M 0.24M
Other current assets 0.01M 0.01M 0.02M 0.01M -0.04M
Total liab 5.69M 5.69M 4.72M 2.75M 1.41M
Total stockholder equity -5.65M -5.65M -4.66M -0.87M -1.15M
Other current liab 1.78M 1.37M 1.07M 0.69M 0.16M
Common stock 0.19M 0.19M 0.11M 0.01M 0.01M
Capital stock - 0.20M 0.12M 0.10M 0.02M
Retained earnings -15.61M -15.61M -13.22M -2.11M -79.51M
Other liab - 0.84M 0.86M 0.77M -
Other assets - - 0.00M -0.08M 0.04M
Cash 0.03M 0.03M 0.00M 0.01M 0.01M
Total current liabilities 5.69M 5.69M 4.71M 2.31M 0.97M
Current deferred revenue 0.42M 0.42M 0.41M -0.28M 0.53M
Net debt 2.82M 2.82M 2.65M 1.50M 0.46M
Short term debt 2.85M 2.85M 2.61M 1.07M 0.03M
Short long term debt - 2.85M 0.17M 2.57M 1.34M
Short long term debt total 2.85M 2.85M 2.65M 1.51M 0.47M
Other stockholder equity 24.44M 9.77M 8.45M 1.46M 68.35M
Property plant equipment - - 0.03M 0.05M 0.05M
Total current assets 0.05M 0.05M 0.02M 1.80M 0.24M
Net tangible assets - -5.65M -4.67M -3.11M -0.87M
Net receivables - - 0.00M 1.77M 0.02M
Long term debt - - 2.43M 0.26M 0.17M
Inventory - - - 0.20M 0.20M
Accounts payable 1.06M 1.06M 0.61M 0.83M 0.25M
Accumulated other comprehensive income 0.29M - - -0.24M 10.00M
Non currrent assets other - 0.00M 0.00M 0.04M 0.08M
Non current assets total - 0.04M 0.04M 0.08M 0.08M
Capital lease obligations - 0.00M 0.06M - -
Breakdown 2021-07-31 2020-07-31 2019-07-31 2018-07-31 2017-07-31
Type yearly yearly yearly yearly yearly
Date 2021-07-31 2020-07-31 2019-07-31 2018-07-31 2017-07-31
Investments 0.00M 0.18M -0.14M -0.05M -
Change to liabilities 0.51M -0.23M 0.17M 0.58M 0.19M
Total cashflows from investing activities - 0.18M -0.14M -0.05M -0.05M
Net borrowings 0.58M 0.36M 1.08M 1.17M -0.94M
Total cash from financing activities 0.58M 0.43M 0.21M -0.50M 0.15M
Change to operating activities -0.01M 0.02M -0.01M -0.01M -0.01M
Net income -2.39M -2.68M -1.81M -13.21M -65.92M
Change in cash 0.03M 0.00M 0.00M 0.01M 0.15M
Begin period cash flow 0.00M 0.00M 0.01M 0.01M 0.00M
End period cash flow 0.03M 0.00M 0.01M 0.01M 0.01M
Total cash from operating activities -0.55M -0.61M -0.16M 0.51M -0.15M
Issuance of capital stock - 0.07M 0.00M - -
Depreciation 0.26M 0.05M 0.02M 0.00M 4.00M
Other cashflows from investing activities - - -0.12M -0.04M -0.04M
Change to inventory - - 0.20M 3.25M 10.78M
Change to account receivables 0.50M 0.50M -0.54M -0.02M 10.92M
Other cashflows from financing activities 0.59M 0.61M 0.53M 0.41M 0.11M
Change to netincome 16.04M 1.73M 7.25M 1.40M 10.28M
Capital expenditures 0.00M 0.02M 0.02M 0.02M 0.02M
Change in working capital 0.50M 0.28M 0.24M 3.42M 10.99M
Stock based compensation 0.96M 0.96M - - -
Other non cash items 1.08M 0.82M 1.40M 10.30M 50.77M
Free cash flow -0.55M -0.61M -0.18M 0.51M -0.15M

Peer Comparison*

Sector: Financial Services Industry: Shell Companies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CLUS
CLUS
-
-%
200.00 - - 0.09 0.92 0.72 -8.97
SGDH
Sgd Holdings Ltd
-
-%
0.02 - - 59741.55 0.56 2.50 -162.10
LION
Lionsgate Studios Holding Corp.
-0.34
2.52%
13.13 - 23.31 1.13 1.35 2.37 5.55
QKIE
QKIE
-
-%
1.94 - - 470.20 - - -

Profile*

Cannagistics Inc

Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York.

150 Motor Parkway, Hauppauge, NY, United States, 11788

631 676 7230

1

Name Title Year Born
Mr. James W. Zimbler VP of Operations & Compliance, Interim Pres, Interim CEO and Director 1966
Mr. Jim Morrison CFO & Chairman 1960
Mr. James W. Zimbler VP of Operations & Compliance, Interim President, Interim CEO and Director 1966
Mr. Jim Morrison CFO & Chairman of the Board 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…